For any new(ish) investors wanting an idea of the value of DXB,...

For any new(ish) investors wanting an idea of the value of DXB, I'd suggest you have a read of:

https://investors.dimerix.com/FormBuilder/_Resource/_module/NmTFFw2QYECW7FAyONzmbw/docs/DXB_20200316_Argonaut_Initiation_Report.pdf

I believe(assume) this was a paid report by DXB, but the values should not be overlooked. At time of posting back in mid March 2020, DXB was not the only company in the process of developing a product for FSGS, so DXB was only given 24% of the valuation of the USD 700 million (AUD 950 million) "per year" USA market. Now that one of the major competitors stopped it's FSGS program, and DXB has had a successful Phase 2a for FSGS, it could be argued that DXB's share will now be significantly higher than the 24%, if it makes it through to production. Then add on the Europe market....

So the current MC of AUD 130 million would appear to be on the cheap side and should have further upward momentum, just the back of FSGS. I'll let you read what positive DKD results would add...

Happy to be corrected, but even if DKD fails (which I personally don't believe it will), apart from a normal sell off against bad news, the outlook for DXB would still be positive.

Of course "do your own research" as they say, but I'd be interest to hear the opinions of others.

Pies